Design and high-throughput implementation of MALDI-TOF/MS-based assays for Parkin E3 ligase activity
Cell Reports Methods · 2024
DOI: 10.1016/j.crmeth.2024.100712 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports Methods, 2024. Verfasst von Ryan Traynor und 10 weiteren Autor:innen. Beteiligte Einrichtung: MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dow St, Dundee DD1 5EH, Scotland, UK. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Parkinson Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, University of Dundee.
Abstract (Originalsprache)
Parkinson's disease (PD) is a progressive neurological disorder that manifests clinically as alterations in movement as well as multiple non-motor symptoms including but not limited to cognitive and autonomic abnormalities. Loss-of-function mutations in the gene encoding the ubiquitin E3 ligase Parkin are causal for familial and juvenile PD. Among several therapeutic approaches being explored to treat or improve the prognosis of patients with PD, the use of small molecules able to reinstate or boost Parkin activity represents a potential pharmacological treatment strategy. A major barrier is the lack of high-throughput platforms for the robust and accurate quantification of Parkin activity in vitro. Here, we present two different and complementary Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight Mass Spectrometry (MALDI-TOF/MS)-based approaches for the quantification of Parkin E3 ligase activity in vitro. Both approaches are scalable for high-throughput primary screening to facilitate the identification of Parkin modulators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dow St, Dundee DD1 5EH, Scotland, UK.
- Vincere Biosciences, Inc., 245 Main St. Fl 2, Cambridge, MA 02142, USA.
- Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
- MRC Protein Phosphorylation and Ubiquitylation Unit Reagents and Services, School of Life Sciences, University of Dundee, Dow St., Dundee DD1 5EH, Scotland, UK.
- MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dow St, Dundee DD1 5EH, Scotland, UK. Electronic address: Vdecesare@dundee.ac.uk.
Förderung
- Wellcome Trust
- Medical Research Council
- University of Dundee
Zitieren
APA
Traynor, R., Moran, J., Stevens, M., Antico, O., Knebel, A., Behrouz, B., Merchant, K., Hastie, C. J., Davies, P., Muqit, M. M. K., & De Cesare, V. (2024). Design and high-throughput implementation of MALDI-TOF/MS-based assays for Parkin E3 ligase activity. Cell Reports Methods. https://doi.org/10.1016/j.crmeth.2024.100712
Vancouver
Traynor R, Moran J, Stevens M, Antico O, Knebel A, Behrouz B, et al. Design and high-throughput implementation of MALDI-TOF/MS-based assays for Parkin E3 ligase activity. Cell Reports Methods. 2024. doi:10.1016/j.crmeth.2024.100712
BibTeX
@article{Traynor2024,
author = {Traynor, Ryan and Moran, Jennifer and Stevens, Michael and Antico, Odetta and Knebel, Axel and Behrouz, Bahareh and Merchant, Kalpana and Hastie, C James and Davies, Paul and Muqit, Miratul M K and De Cesare, Virginia},
title = {Design and high-throughput implementation of MALDI-TOF/MS-based assays for Parkin E3 ligase activity},
journal = {Cell Reports Methods},
year = {2024},
doi = {10.1016/j.crmeth.2024.100712}
}
EUVIMED